The COVID-19 pandemic has redirected healthcare resources towards combating the virus, leaving traditional diagnostic tests limited. Evidence suggests direct cardiac involvement in COVID-19, necessitating careful monitoring of patients with preexisting cardiovascular conditions. Holter-ECG monitoring provides a remote and reliable solution for assessing arrhythmic risks, highlighting the need to adapt healthcare management strategies during the pandemic.